← Back to Search

Orthopedic Implant

Hip Replacement Implants for Osteoarthritis

N/A
Waitlist Available
Research Sponsored by Medacta USA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary osteoarthritis of the hip necessitating primary hip replacement
Adult male and female under 75 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-operative, 4-8 weeks post-operative, 4-8 months post-operative, 9-15 months post operative, 18-30 months post-operative, 4-6 years post-operative, 9-11 years post-operative.
Awards & highlights

Study Summary

This trial will study the hip function and quality of life of patients who had surgery to replace their hip with a Medacta International SA Masterloc femoral stem and MPACT acetabular cup.

Who is the study for?
This trial is for adults under 75 with primary osteoarthritis of the hip needing a replacement, who can consent and commit to follow-up. It excludes those with prior hip surgery, pregnancy or plans to become pregnant, severe osteoporosis, post-traumatic or congenital deformities in the hip, active infections, inflammatory arthritis like rheumatoid arthritis, or personality disorders.Check my eligibility
What is being tested?
The study tests how well patients do after getting a Masterloc femoral stem and MPACT acetabular cup implant in their hips. It looks at hip function and quality of life post-surgery to assess these implants' performance and long-term success rate.See study design
What are the potential side effects?
While not specified here, typical side effects from similar surgeries may include pain at the site of surgery, swelling around the hip area, risk of infection at the incision site or inside joint space; there's also a small chance of dislocation or loosening over time.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need a hip replacement due to severe arthritis.
Select...
I am under 75 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-operative, 4-8 weeks post-operative, 4-8 months post-operative, 9-15 months post operative, 18-30 months post-operative, 4-6 years post-operative, 9-11 years post-operative.
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-operative, 4-8 weeks post-operative, 4-8 months post-operative, 9-15 months post operative, 18-30 months post-operative, 4-6 years post-operative, 9-11 years post-operative. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
EuroQol 5 dimension (EQ-5D)
Harris Hip Score (HHS)
Hip Disability and Osteoarthritis Outcome Score (HOOS)
+2 more
Secondary outcome measures
Radiographic analysis

Trial Design

1Treatment groups
Experimental Treatment
Group I: Femoral Component:Medacta Masterloc Stem and Medacta MPACT cupExperimental Treatment1 Intervention
All patients enrolled will receive the Medacta Masterloc Stem and MPACT cup with Highcross PE liner.

Find a Location

Who is running the clinical trial?

Medacta USALead Sponsor
16 Previous Clinical Trials
1,960 Total Patients Enrolled
10 Trials studying Osteoarthritis
949 Patients Enrolled for Osteoarthritis

Media Library

Medacta Masterloc Stem (Orthopedic Implant) Clinical Trial Eligibility Overview. Trial Name: NCT03168750 — N/A
Osteoarthritis Research Study Groups: Femoral Component:Medacta Masterloc Stem and Medacta MPACT cup
Osteoarthritis Clinical Trial 2023: Medacta Masterloc Stem Highlights & Side Effects. Trial Name: NCT03168750 — N/A
Medacta Masterloc Stem (Orthopedic Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03168750 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What site did they apply to?
Tucson Othropedic Institute
What portion of applicants met pre-screening criteria?
Met criteria
~15 spots leftby Apr 2025